Found 15 matching trials
Post-licensure Safety Study of IMOJEV® in Thailand PHASE4 The aim of this study is to further characterize the safety profile of IMOJ...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine PHASE4 This study aims to provide evidence that co-administration of measles-mumps...
Show More Location
Research Institute for Tropical Medicine
Learn More & Join Trial
Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers PHASE3 The purpose of this study is to compare Live Attenuated Japanese Encephalit...
Show More Location
Multiple Locations
Learn More & Join Trial
Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine PHASE3 This study will determine whether it is safe and effective to administer Ja...
Show More Location
Research Institute for Tropical Medicine
Learn More & Join Trial
Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea PHASE3 The aim of this study was to document the immunogenicity and safety of a bo...
Show More Location
Investigational Site 004
Learn More & Join Trial
Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®) PHASE2 The purpose of this study is to obtain safety, tolerability, and immunogeni...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis. PHASE3 The purpose of this study is to assess whether ChimeriVax™ JE vaccine (a ne...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers PHASE3 This study is designed to compare the immunogenicity of Japanese encephalit...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects. PHASE1 Phase 1 study to evaluate two doses of Alum Adjuvanted Zika Virus Purified ...
Show More Location
Walter Reed Army Institute of Research - Clinical Trials Center
Learn More & Join Trial
Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects PHASE3 The purpose of this study is to describe the immunogenicity and safety of I...
Show More Location
Preventive Medicine Centre of Hoa Binh Province
Learn More & Join Trial